CRISPR News and Research

Latest CRISPR News and Research

Targeting the hemoglobin problem in sickle cell disease using a new drug

A class of drugs used for their ability to stop tumor cells from dividing is now under study for their potential to reduce the pain and damage caused by sickle cell disease, investigators report.

11 May 2023

New CRISPR genome-editing technology helps scientists to explore many cancer-linked mutations

Genomic studies of cancer patients have revealed thousands of mutations linked to tumor development.

11 May 2023

Study identifies key genetic mechanism of drug resistance in the deadliest malaria parasites

An important genetic mechanism of drug resistance in one of the deadliest human malaria parasites has been identified in a new study published in Nature Microbiology.

11 May 2023

ELRIG UK appoints Nick Clare to board as Vendor Strategy Work Group Lead

The European Laboratory Research & Innovation Group (ELRIG) UK today announced the appointment of Nick Clare to the ELRIG board. He will chair and lead the Vendor Strategy Work Group to help ensure the vendors’ perspectives and interests are represented within the ELRIG board.

From ELRIG (UK) Ltd. 11 May 2023

Leveraging proteomics datasets to discover potential therapeutic targets for cancer patients

A new research perspective was published in Oncotarget's Volume 14 on May 4, 2023, entitled, "Using cancer proteomics data to identify gene candidates for therapeutic targeting."

10 May 2023

AI tools can help simplify a test that works for hepatitis C and SARS-CoV-2

Going beyond pregnancy and COVID-19, the world could someday soon come to rely on at-home tests for many diseases thanks in part to AI-fueled improvements.

8 May 2023

First CRISPR-armed phage therapeutic can specifically target and remove E. coli in the human gut

SNIPR Biome ApS ("SNIPR"), the company pioneering CRISPR-based microbial gene therapy, announces today that Nature Biotechnology has published research findings from its preclinical work on SNIPR001, the first CRISPR-armed phage therapeutic developed to specifically target and remove E. coli, including antibiotic-resistant strains, in the human gastrointestinal tract.

8 May 2023

New approach addresses the challenge of directly connecting genetic variants to human traits, health

A major challenge in human genetics is understanding which parts of the genome drive specific traits or contribute to disease risk. This challenge is even greater for genetic variants found in the 98% of the genome that does not encode proteins.

5 May 2023

Wistar scientists uncover a key mechanism as to how p53 suppresses tumors

The p53 gene is one of the most important in the human genome: the only role of the p53 protein that this gene encodes is to sense when a tumor is forming and to kill it.

5 May 2023

Exploring the World of RNA Chemistry

In this interview conducted at Pittcon 2023 in Philadelphia, Pennsylvania, we spoke to Philip Bevilacqua from Pennsylvania State University about the world of RNA chemistry.

From Pittcon 5 May 2023

Organoid models provide new scientific insights into a rare childhood liver cancer

Scientists of the Princess Máxima Center for pediatric oncology and Hubrecht Institute in the Netherlands have revealed new scientific insights into the features of fibrolamellar carcinoma (FLC), a rare type of childhood liver cancer

3 May 2023

Researchers develop gene-edited stem cells to reduce arrhythmias in heart attack patients

In a recent study published in the journal Cell Stem Cell, researchers hypothesized that pacemaker-like activity of human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) resulted in engraftment arrhythmias (EAs), which hampers the clinical use of cell-based therapy using hPSC-CMs for treatment of myocardial infarction (MI).

2 May 2023

CRISPR-Cas9 system can help reduce adenovirus replication in human cells

The replication of potentially harmful adenoviruses can be significantly reduced in human cells in cell culture by using the so-called CRISPR-Cas9 system ("gene scissors")

29 Apr 2023

Fighting tuberculosis with the new MTB Strip Test Kit

Lecturers of the Faculty of Allied Health Sciences, Chulalongkorn University have developed MTB Strip Test Kit for Tuberculosis (TB) diagnosis that's accurate and easy to use, guaranteed by the 2023 Invention Award from the National Research Council of Thailand (NRCT) -; Another hope to reduce the spread of tuberculosis in Thailand.

28 Apr 2023

New approach for efficient engineering of cell and gene therapies

A new approach to the genetic engineering of cells promises significant improvements in speed, efficiency, and reduction in cellular toxicity compared to current methods.

28 Apr 2023

Study uncovers new clues and raises more questions about CRISPR

CRISPR claimed scientific fame for its ability to quickly and accurately edit genes. But, at the core, CRISPR systems are immune systems that help bacteria protect themselves from viruses by targeting and destroying viral DNA and RNA.

27 Apr 2023

Developing Next-Generation Nanomaterials for Medical Applications

In this interview conducted at Pittcon 2023 in Philadelphia, Pennsylvania, we spoke to Dr. Chad Merkin, Director of the International Institute for Nanotechnology, about his work developing next-generation nanomaterials for medical applications.

From Pittcon 27 Apr 2023

UQ research could lead to viable treatments for motor neuron disease

Research at The University of Queensland could eventually help develop viable treatments - and ultimately a cure - for motor neuron disease (MND).

26 Apr 2023

New nanoparticle sensor could enable early cancer diagnosis with a simple urine test

MIT engineers have designed a new nanoparticle sensor that could enable early diagnosis of cancer with a simple urine test. The sensors, which can detect many different cancerous proteins, could also be used to distinguish the type of a tumor or how it is responding to treatment.

25 Apr 2023

Researchers pioneer a new method for fast miRNA amplification and detection

In the early 1990s, scientists who were studying the development of a roundworm identified a small RNA molecule that regulated the expression of specific genes.

24 Apr 2023

CRISPR News and Research

Latest CRISPR News and Research

Targeting the hemoglobin problem in sickle cell disease using a new drug

New CRISPR genome-editing technology helps scientists to explore many cancer-linked mutations

Study identifies key genetic mechanism of drug resistance in the deadliest malaria parasites

ELRIG UK appoints Nick Clare to board as Vendor Strategy Work Group Lead

Leveraging proteomics datasets to discover potential therapeutic targets for cancer patients

AI tools can help simplify a test that works for hepatitis C and SARS-CoV-2

First CRISPR-armed phage therapeutic can specifically target and remove E. coli in the human gut

New approach addresses the challenge of directly connecting genetic variants to human traits, health

Wistar scientists uncover a key mechanism as to how p53 suppresses tumors

Exploring the World of RNA Chemistry

Organoid models provide new scientific insights into a rare childhood liver cancer

Researchers develop gene-edited stem cells to reduce arrhythmias in heart attack patients

CRISPR-Cas9 system can help reduce adenovirus replication in human cells

Fighting tuberculosis with the new MTB Strip Test Kit

New approach for efficient engineering of cell and gene therapies

Study uncovers new clues and raises more questions about CRISPR

Developing Next-Generation Nanomaterials for Medical Applications

UQ research could lead to viable treatments for motor neuron disease

New nanoparticle sensor could enable early cancer diagnosis with a simple urine test

Researchers pioneer a new method for fast miRNA amplification and detection

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production